233 related articles for article (PubMed ID: 37519231)
41. Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells.
Brill SR; Ross KE; Davidow CJ; Ye M; Grantham JJ; Caplan MJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10206-11. PubMed ID: 8816777
[TBL] [Abstract][Full Text] [Related]
42. Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo.
Cabrita I; Kraus A; Scholz JK; Skoczynski K; Schreiber R; Kunzelmann K; Buchholz B
Nat Commun; 2020 Aug; 11(1):4320. PubMed ID: 32859916
[TBL] [Abstract][Full Text] [Related]
43. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.
Brill AL; Ehrlich BE
Cell Signal; 2020 Feb; 66():109490. PubMed ID: 31805375
[TBL] [Abstract][Full Text] [Related]
44. Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins.
Xu T; Chen M; Xu Q; Xue C; Fu L; Ling K; Hu J; Mei C
Front Biosci (Landmark Ed); 2022 Jul; 27(7):216. PubMed ID: 35866397
[TBL] [Abstract][Full Text] [Related]
45. Autosomal dominant polycystic kidney disease is associated with an increased prevalence of radiographic bronchiectasis.
Driscoll JA; Bhalla S; Liapis H; Ibricevic A; Brody SL
Chest; 2008 May; 133(5):1181-8. PubMed ID: 18263686
[TBL] [Abstract][Full Text] [Related]
46. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
[TBL] [Abstract][Full Text] [Related]
47. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
[TBL] [Abstract][Full Text] [Related]
48. Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins.
Kunzelmann K; Ousingsawat J; Kraus A; Park JH; Marquardt T; Schreiber R; Buchholz B
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686084
[TBL] [Abstract][Full Text] [Related]
49. Polycystin-1 surface localization is stimulated by polycystin-2 and cleavage at the G protein-coupled receptor proteolytic site.
Chapin HC; Rajendran V; Caplan MJ
Mol Biol Cell; 2010 Dec; 21(24):4338-48. PubMed ID: 20980620
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
[TBL] [Abstract][Full Text] [Related]
51. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
[TBL] [Abstract][Full Text] [Related]
52. A regulatory role of polycystin-1 on cystic fibrosis transmembrane conductance regulator plasma membrane expression.
Ikeda M; Fong P; Cheng J; Boletta A; Qian F; Zhang XM; Cai H; Germino GG; Guggino WB
Cell Physiol Biochem; 2006; 18(1-3):9-20. PubMed ID: 16914886
[TBL] [Abstract][Full Text] [Related]
53. Functional Study of the Primary Cilia in ADPKD.
Ko JY
Adv Exp Med Biol; 2016; 933():45-57. PubMed ID: 27730434
[TBL] [Abstract][Full Text] [Related]
54. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.
Ko JY; Yoo KH; Song SA; Kim DY; Kong HK; Ahn C; Lee HW; Kang DH; Oh GT; Park JH
J Biol Chem; 2013 Mar; 288(9):6488-97. PubMed ID: 23316056
[TBL] [Abstract][Full Text] [Related]
56. PF-06409577 inhibits renal cyst progression by concurrently inhibiting the mTOR pathway and CFTR channel activity.
Su L; Yuan H; Zhang H; Wang R; Fu K; Yin L; Ren Y; Liu H; Fang Q; Wang J; Guo D
FEBS Open Bio; 2022 Oct; 12(10):1761-1770. PubMed ID: 35748097
[TBL] [Abstract][Full Text] [Related]
57. Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells.
Yuajit C; Muanprasat C; Homvisasevongsa S; Chatsudthipong V
Biomed Pharmacother; 2017 Oct; 94():820-826. PubMed ID: 28802235
[TBL] [Abstract][Full Text] [Related]
58. Cell-Autonomous Hedgehog Signaling Is Not Required for Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ma M; Legué E; Tian X; Somlo S; Liem KF
J Am Soc Nephrol; 2019 Nov; 30(11):2103-2111. PubMed ID: 31451534
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
[TBL] [Abstract][Full Text] [Related]
60. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
